Advancing Prostate Brachytherapy - High Doses and Conformity

Alfonso Gomez-Iturriaga, MD, PhD, recognizes prostate brachytherapy’s universal appeal to physicians. Many recognize its significant advantage in nominal dose administration to the prostate and its potential impact on patients with a high risk of recurrence.

Brachytherapy’s offering of a unique approach in administering higher doses of radiation directly to the prostate with low integral dose and excellent dose distribution, makes precision an appealing option for physicians aiming to achieve targeted treatment with minimal impact on surrounding tissue.
Offering doctors the opportunity to establish such a program is compelling, as the benefits of brachytherapy align with their beliefs:

• High doses
• Low integral dose
• Exceptional dose distribution
• Conformity to regions requiring heightened radiation.

Find out more on the future of prostate cancer treatment with Elekta brachytherapy.
Clinical Brachytherapy | Products | Cancer Treatment | Elekta
Brachytherapy For Prostate Cancer | Products | Elekta